Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode

Yahoo FinanceNov 19 21:53

This Biotech's Stock Could Double If Its Treatment for Major Depressive Disorder Succeeds, Says Mizuho

MarketWatchNov 14 00:03

RBC Capital Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $29

Futu NewsNov 13 20:31 · Ratings

H.C. Wainwright Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $30

Futu NewsNov 13 19:31 · Ratings

Neumora Therapeutics, Inc.: Strategic Advancements and Unique Efficacy in MDD Trials Drive Buy Rating

TipRanksNov 13 19:26 · Ratings

Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $23

Futu NewsNov 13 18:38 · Ratings